dalteparin has been researched along with Priapism in 8 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Priapism: A prolonged painful erection that may lasts hours and is not associated with sexual activity. It is seen in patients with SICKLE CELL ANEMIA, advanced malignancy, spinal trauma; and certain drug treatments.
Excerpt | Relevance | Reference |
---|---|---|
"Priapism is a rare disorder defined as a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation." | 5.35 | Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency. ( Abu Sham'a, RA; Kufri, FH; Yassin, IH, 2008) |
"A 35-year-old man developed priapism with the use of low-molecular-weight heparin and warfarin following repair of left brachial artery sustained after gunshot injury." | 3.78 | Anticoagulant-induced priapism progressing to penile gangrene: a devastating complication! ( Goel, A; Kumar, A; Nagathan, DS; Pahwa, HS, 2012) |
"Penile thrombosis has not been reported as a thrombotic complication of SARS-CoV-2 infection with hypercoagulability." | 1.62 | Priapism in a patient with coronavirus disease 2019 (COVID-19). ( Abbad, S; Chebbi, A; Lamamri, M; Legriel, S; Mamane, J; Munuzzolini, M; Sarfati, F, 2021) |
"Priapism is a rare disorder defined as a persistent penile erection that continues hours beyond, or is unrelated to, sexual stimulation." | 1.35 | Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency. ( Abu Sham'a, RA; Kufri, FH; Yassin, IH, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lamamri, M | 1 |
Chebbi, A | 1 |
Mamane, J | 1 |
Abbad, S | 1 |
Munuzzolini, M | 1 |
Sarfati, F | 1 |
Legriel, S | 1 |
Gomez Gomez, E | 1 |
Campos Hernandez, JP | 1 |
Cazalilla, M | 1 |
TriviƱo, F | 1 |
Barbudo, J | 1 |
Prieto, R | 1 |
Requena Tapia, MJ | 1 |
Abu Sham'a, RA | 1 |
Kufri, FH | 1 |
Yassin, IH | 1 |
Izzedine, H | 1 |
Gharbi, C | 1 |
Alperin, S | 1 |
Bourry, E | 1 |
Cluzel, P | 1 |
Nagathan, DS | 1 |
Pahwa, HS | 1 |
Kumar, A | 1 |
Goel, A | 1 |
Lin, PH | 1 |
Bush, RL | 1 |
Lumsden, AB | 1 |
Bouchier-Hayes, D | 1 |
Nolan, P | 1 |
Pate, G | 1 |
Purnell, J | 1 |
Abdulla, AN | 1 |
8 other studies available for dalteparin and Priapism
Article | Year |
---|---|
Priapism in a patient with coronavirus disease 2019 (COVID-19).
Topics: Anticoagulants; COVID-19; Enoxaparin; Humans; Male; Middle Aged; Priapism; Thrombosis | 2021 |
Partial thrombosis of the corpus cavernosum: should we dig deeper into coagulopathy disorders?
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Factor V; Humans; Magnetic Resonance | 2016 |
Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency.
Topics: Adult; Anticoagulants; Enoxaparin; Humans; Male; Priapism; Protein C Deficiency; Pulmonary Embolism; | 2008 |
Orthostatic stuttering priapism in a HIV positive man.
Topics: Anticoagulants; Enoxaparin; HIV Seropositivity; Humans; Male; Middle Aged; Priapism; Quality of Life | 2009 |
Anticoagulant-induced priapism progressing to penile gangrene: a devastating complication!
Topics: Adult; Anticoagulants; Brachial Artery; Dalteparin; Drug Therapy, Combination; Gangrene; Hemopneumot | 2012 |
Low molecular weight heparin induced priapism.
Topics: Anticoagulants; Automobile Driving; Dalteparin; Humans; Male; Middle Aged; Priapism; Venous Thrombos | 2004 |
Treatment-resistant priapism associated with long-term low-molecular-weight heparin.
Topics: Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Penile Prosthesis; Penis; Phenylephrine; P | 2021 |
Case report: ischemic priapism secondary to tinzaparin.
Topics: Adult; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Priapism; Thrombosis; Tinza | 2018 |